ScoreWhy is Biomerica, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Net Sales has grown by an annual rate of -4.52% and Operating profit at -167.65% over the last 5 years
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -6.93%, its profits have risen by 23.6%
4
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -4.34% over the previous quarter and collectively hold 15.02% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Below par performance in long term as well as near term
- Along with generating -6.93% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Biomerica, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Biomerica, Inc.
-27.43%
-0.07
684.07%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.52%
EBIT Growth (5y)
-167.65%
EBIT to Interest (avg)
-5.74
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.86
Tax Ratio
0.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.02%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.55
EV to EBIT
-1.16
EV to EBITDA
-1.25
EV to Capital Employed
2.09
EV to Sales
1.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-180.43%
ROE (Latest)
-87.64%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -3.83 MM
NET PROFIT(HY)
Higher at USD -2.71 MM
-9What is not working for the Company
ROCE(HY)
Lowest at -92.99%
RAW MATERIAL COST(Y)
Grown by 4,350.63% (YoY
CASH AND EQV(HY)
Lowest at USD 5.46 MM
OPERATING PROFIT(Q)
Lowest at USD -1.46 MM
PRE-TAX PROFIT(Q)
Lowest at USD -1.54 MM
NET PROFIT(Q)
Lowest at USD -1.54 MM
Here's what is working for Biomerica, Inc.
Operating Cash Flow
Highest at USD -3.83 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Here's what is not working for Biomerica, Inc.
Operating Profit
Lowest at USD -1.46 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -1.54 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -1.54 MM has Fallen at -27.03%
over average net sales of the previous four periods of USD -1.21 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -1.54 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Profit
At USD -1.54 MM has Fallen at -27.34%
over average net sales of the previous four periods of USD -1.21 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Cash and Eqv
Lowest at USD 5.46 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 4,350.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
